| Identification | Back Directory | [Name]
(1R,2S,3S,4R,5R)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol | [CAS]
1210344-30-1 | [Synonyms]
(3R,4S,5S)-3,4,5-tris-benzyloxy-6,6-bis-(4-methoxybenzyloxymethyl)tetrahydropyran-2-one
(3R,4S,5S)-3,4,5-tris(benzyloxy)-6,6-bis(((4-methoxybenzyl)oxy)methyl)tetrahydro-2H-pyran-2-one
Please quote for 25g/50g of 3R,4S,5S)-3,4,5-tris-benzyloxy-6,6-bis-(4-Methoxy-benzyloxy-methyl)-tet
(1R,2S,3S,4R,5R)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
D-xylo-Hexonic acid, 5-C-[[(4-methoxyphenyl)methoxy]methyl]-6-O-[(4-methoxyphenyl)methyl]-2,3,4-tris-O-(phenylmethyl)-, δ-lactone | [Molecular Formula]
C44H46O9 | [MOL File]
1210344-30-1.mol | [Molecular Weight]
718.83 |
| Hazard Information | Back Directory | [Uses]
(1R,2S,3S,4R,5R)-5-(4-Chloro-3-(4-ethoxybenzyl)phenyl-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol is an ertugliflozin impurity with potential research applications, Ertugliflozin (CAS: 1210344-57-2) is explored for long term efficacy and safety for treatment of type-2 diabetes. |
|
|